Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTION outpatient induction of labour trial
2023-507164-39-00Phase 4Authorised
- Sponsor
- Region Västra Götaland
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of misoprostol (2 arms), sponsored by Region Västra Götaland. Primary endpoints: Safety defined as a composite outcome of severe perinatal morbidity or mortality and Proportion of women with vaginal delivery. Planned start Oct 2023; status: authorised.
02
Drugs
misoprostol
Beyond the preview
Go deeper on 2023-507164-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507164-39-00.